论文部分内容阅读
目的:探讨倍他乐克对扩张型心肌病疗效和药理。方法:将60例扩张型心肌病患者随机分为对照组和观察组,对照组30例给予常规抗心力衰竭治疗,观察组30例在对照组基础上加用倍他乐克治疗。比较两组患者治疗后心率、血压以及超声指标。结果:对照组治疗总有效率为76.7%;观察组治疗总有效率为90.0%。两组治疗效果比较,差异具有统计学意义(P<0.05)。治疗后,对两组患者血压、超声指标、心率等各项指标比较,观察组各项指标均明显优于对照组,差异具有统计学意义(P<0.05)。结论:采用倍他乐克治疗扩张性心肌病可以有效改善患者临床症状。
Objective: To investigate the efficacy and pharmacology of Betaloc on dilated cardiomyopathy. Methods: Sixty patients with dilated cardiomyopathy were randomly divided into control group and observation group, 30 cases in control group were given conventional anti-heart failure treatment, 30 cases in observation group were treated with Betaloc on the basis of control group. After treatment, heart rate, blood pressure and ultrasound indexes were compared between the two groups. Results: The total effective rate of the control group was 76.7%. The total effective rate of the observation group was 90.0%. The two groups of treatment effect, the difference was statistically significant (P <0.05). After treatment, the two groups of patients with blood pressure, ultrasound, heart rate and other indicators of comparison, the observation group indicators were significantly better than the control group, the difference was statistically significant (P <0.05). Conclusion: The treatment of dilated cardiomyopathy with metoprolol can effectively improve the clinical symptoms of patients.